SlideShare a Scribd company logo
1 of 22
Wat is die speekselkliertumor?
MRI van speekselkliertumoren.
  Aart I. Issa-Epe, AIOS radiologie MCA
      B.M. Wiarda, radioloog MCA
Doel
• Kort overzicht van meest voorkomende
  speekselkliertumoren aan de hand van MRI-
  karakteristieken
Protocol

Sequentie                   Richting
   STIR                       Axiaal
  T1 SE                       Axiaal
PD/T2 TSE                     Axiaal
Post-contrast              Post-contrast
  T1 SE                       Axiaal
 T1 SE FS                   Coronaal
Beoordeling
Benigne                        Maligne

Grootte speekselklier         Grootte speekselklier 

                               Infiltratie

Scherp                         Onscherp

Beperkt                        Uitbreiding

Geen zenuwbetrekking           Betrekking N VII

Geen lymfadenopathie           Lymfadenopathie
Tumorkenmerken
             T1      T2   T1+C   PET
Pleiomorf                +      -       Scherp, homogeen
adenoom                                      aankleurend
 Warthin           =/    -      +       Scherp, heterogeen,
                                         bilateraal/multifocaal
Lymfoom       =     /    +      +      Meerdere homogene
                                         massa’s of infiltratief
Mucoepider   /=    /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=          +      +      Infiltratief, homogeen
cysteus ca                                  aankleurend, lnn
Casus 1




T2             T1




     STIR             T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                                T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                                T1+C
Casus 2


                   T1


     STIR               T1




T2          T1+C             PET
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                             T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                             T1+C
Casus 3



T1     T2             STIR




T1+C   T1+C           PET
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                              T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                              T1+C
Casus 4




T1            T2




     STIR             T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                             T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                             T1+C
Casus 5




T2   STIR         T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                              T1+C
T1    T2    T1+C   PET
Pleiomorf               +      -       Scherp, homogeen
adenoom                                     aankleurend
 Warthin          =/    -      +       Scherp, heterogeen,
                                        bilateraal/multifocaal
Lymfoom       =    /    +      +      Meerdere homogene
                                        massa’s of infiltratief
Mucoepider   /=   /=   +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=         +      +      Infiltratief, homogeen
cysteus ca                                 aankleurend, lnn




                                              T1+C
Conclusie
             T1    T2     T1+C   PET
Pleiomorf                +      -       Scherp, homogeen
adenoom                                      aankleurend
 Warthin          =/     -      +       Scherp, heterogeen,
                                         bilateraal/multifocaal
Lymfoom       =    /     +      +      Meerdere homogene
                                         massa’s of infiltratief
Mucoepider   /=   /=    +/-     -    Onscherp, heterogeen, lnn
 moid ca

 Adenoid     /=          +      +      Infiltratief, homogeen
cysteus ca                                  aankleurend, lnn
Literatuur
•   Harnsberger HR. Diagnostic Imaging Head and Neck 2nd ed. Amirsys, 2011; I-5-1 – I-5-43.
•   Youssem DM, Kraut MA, Chalian AA. Major Salivary Gland Imaging. Radiology 1999; 1-34.
•   Yabuuchi H et al. Parotid Gland Tumors: Can Addition of Diffusion-weighted MR Imaging to
    Dynamic Contrast-enhanced MR Imaging Improve Diagnostic Accuracy in Characterization?
    Radiology 2008; 1-21.
•   Teresesi LM et al. Parotid Masses: MR Imaging. Head and Neck Radiology 1987; 163: 405-
    409.
•   Yamaguchi S et al. Parotid Tumor Statistics for the Past Five Years. Practica Otologica 2004;
    97: 713 – 718.
•   UCLA School of Medicine website: http://wwwpathnet.medsch.ucla.edu/med-
    edu/pathrev/saliv/mt/acinic.htm.
•   The Doctor’s Doctor.com page on Acinic Cell
    Carcinoma: http://www.thedoctorsdoctor.com/diseases/aciniccell_ca.htm.
•   National Cancer Data Base Report on Cancer of the Head and Neck: Acinic Cell Carcinoma
    (multi-institution report). Published : Head and Neck - July 1999. Authors: Henry T. Hoffman
    MD, Lucy Hynds Karnell PhD, Robert A. Robinson, MD, John A. Pinkston MD, Herman R.
    Menck MBA.

More Related Content

Featured

Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
 

Featured (20)

PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
 
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
 
ChatGPT webinar slides
ChatGPT webinar slidesChatGPT webinar slides
ChatGPT webinar slides
 
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike RoutesMore than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
 
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
 
Barbie - Brand Strategy Presentation
Barbie - Brand Strategy PresentationBarbie - Brand Strategy Presentation
Barbie - Brand Strategy Presentation
 

Speekselkliertumoren Radiologendagen 2012 Aart Issa

  • 1. Wat is die speekselkliertumor? MRI van speekselkliertumoren. Aart I. Issa-Epe, AIOS radiologie MCA B.M. Wiarda, radioloog MCA
  • 2. Doel • Kort overzicht van meest voorkomende speekselkliertumoren aan de hand van MRI- karakteristieken
  • 3. Protocol Sequentie Richting STIR Axiaal T1 SE Axiaal PD/T2 TSE Axiaal Post-contrast Post-contrast T1 SE Axiaal T1 SE FS Coronaal
  • 4. Beoordeling Benigne Maligne Grootte speekselklier  Grootte speekselklier  Infiltratie Scherp Onscherp Beperkt Uitbreiding Geen zenuwbetrekking Betrekking N VII Geen lymfadenopathie Lymfadenopathie
  • 5. Tumorkenmerken T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn
  • 6. Casus 1 T2 T1 STIR T1+C
  • 7. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 8. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 9. Casus 2 T1 STIR T1 T2 T1+C PET
  • 10. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 11. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 12. Casus 3 T1 T2 STIR T1+C T1+C PET
  • 13. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 14. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 15. Casus 4 T1 T2 STIR T1+C
  • 16. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 17. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 18. Casus 5 T2 STIR T1+C
  • 19. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 20. T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn T1+C
  • 21. Conclusie T1 T2 T1+C PET Pleiomorf   + - Scherp, homogeen adenoom aankleurend Warthin  =/ - + Scherp, heterogeen, bilateraal/multifocaal Lymfoom = / + + Meerdere homogene massa’s of infiltratief Mucoepider /= /= +/- - Onscherp, heterogeen, lnn moid ca Adenoid /=  + + Infiltratief, homogeen cysteus ca aankleurend, lnn
  • 22. Literatuur • Harnsberger HR. Diagnostic Imaging Head and Neck 2nd ed. Amirsys, 2011; I-5-1 – I-5-43. • Youssem DM, Kraut MA, Chalian AA. Major Salivary Gland Imaging. Radiology 1999; 1-34. • Yabuuchi H et al. Parotid Gland Tumors: Can Addition of Diffusion-weighted MR Imaging to Dynamic Contrast-enhanced MR Imaging Improve Diagnostic Accuracy in Characterization? Radiology 2008; 1-21. • Teresesi LM et al. Parotid Masses: MR Imaging. Head and Neck Radiology 1987; 163: 405- 409. • Yamaguchi S et al. Parotid Tumor Statistics for the Past Five Years. Practica Otologica 2004; 97: 713 – 718. • UCLA School of Medicine website: http://wwwpathnet.medsch.ucla.edu/med- edu/pathrev/saliv/mt/acinic.htm. • The Doctor’s Doctor.com page on Acinic Cell Carcinoma: http://www.thedoctorsdoctor.com/diseases/aciniccell_ca.htm. • National Cancer Data Base Report on Cancer of the Head and Neck: Acinic Cell Carcinoma (multi-institution report). Published : Head and Neck - July 1999. Authors: Henry T. Hoffman MD, Lucy Hynds Karnell PhD, Robert A. Robinson, MD, John A. Pinkston MD, Herman R. Menck MBA.

Editor's Notes

  1. Pleiomorf adenoom
  2. Warthin
  3. NHL
  4. Mucoepidermoid carcinoom
  5. Adenoid cysteus carcinoom